Athanase Innovation AB
SSE:ATIN.ST
15.9 (SEK) • At close February 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 49.742 | 17.553 | 35.373 | 15.798 | 3.475 | 1.861 | 10.912 | 1.747 | 3.071 | 2.957 | -1.396 | 2.878 | 0.523 | 11.234 | 0 | 0 | 0 |
Cost of Revenue
| 63.139 | 3.395 | 49.95 | 46.553 | 25.679 | 3.76 | 3.93 | 29.537 | 22.284 | 21.654 | 16.973 | 14.296 | 10.99 | 1.626 | 0 | 0 | 0 |
Gross Profit
| -13.397 | 14.158 | -14.577 | -30.755 | -22.204 | -1.899 | 6.982 | -27.79 | -19.213 | -18.697 | -18.369 | -11.418 | -10.467 | 9.608 | 0 | 0 | 0 |
Gross Profit Ratio
| -0.269 | 0.807 | -0.412 | -1.947 | -6.39 | -1.02 | 0.64 | -15.907 | -6.256 | -6.323 | 13.158 | -3.967 | -20.013 | 0.855 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0 | 21.968 | 21.701 | 22.334 | 20.241 | 21.549 | 23.007 | 23.586 | 17.361 | 16.904 | 12.791 | 8.537 | 6.246 | 7.729 | 0.028 | 0.18 | 0.03 |
Other Expenses
| 0 | 7.589 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 0 | 29.557 | 22.653 | 29.176 | 22.834 | 21.549 | 23.007 | 22.42 | 19.455 | 19.452 | 16.037 | 12.718 | 26.779 | 11.547 | 0.028 | 1.901 | 0.03 |
Operating Income
| -13.397 | -15.399 | -14.577 | -30.755 | -22.204 | -25.309 | -26.937 | -27.79 | -19.213 | -18.697 | -18.369 | -11.418 | -10.467 | -1.939 | -0.028 | -0.18 | -0.03 |
Operating Income Ratio
| -0.269 | -0.877 | -0.412 | -1.947 | -6.39 | -13.6 | -2.469 | -15.907 | -6.256 | -6.323 | 13.158 | -3.967 | -20.013 | -0.173 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -11.874 | -1.872 | 38.709 | 7.499 | 12.648 | 7.503 | 11.803 | 17.907 | -14.176 | -39.076 | -4.202 | 3.732 | -10.198 | -15.057 | 15.03 | -1.835 | 0 |
Income Before Tax
| -25.271 | -17.271 | 24.132 | -23.256 | -9.556 | -17.806 | -15.134 | -9.883 | -33.389 | -57.773 | -22.571 | -7.686 | -20.665 | -16.996 | 15.002 | -2.015 | -0.03 |
Income Before Tax Ratio
| -0.508 | -0.984 | 0.682 | -1.472 | -2.75 | -9.568 | -1.387 | -5.657 | -10.872 | -19.538 | 16.168 | -2.671 | -39.512 | -1.513 | 0 | 0 | 0 |
Income Tax Expense
| -11.6 | 5.474 | 0.743 | -10.83 | 0.687 | -0.046 | -0.081 | -9.156 | -0.081 | -0.081 | 0.232 | -6.62 | 1.028 | 1.293 | 3.09 | 6.652 | 0 |
Net Income
| -25.271 | -17.229 | 23.389 | -13.208 | -10.243 | -17.76 | -15.053 | -0.727 | -33.308 | -57.692 | -22.803 | -1.426 | -21.98 | -15.056 | 11.912 | -8.667 | -0.03 |
Net Income Ratio
| -0.508 | -0.982 | 0.661 | -0.836 | -2.948 | -9.543 | -1.379 | -0.416 | -10.846 | -19.51 | 16.335 | -0.495 | -42.027 | -1.34 | 0 | 0 | 0 |
EPS
| -1.07 | -0.71 | 0.93 | -0.48 | -0.35 | -0.57 | -0.48 | -0.023 | -1.07 | -1.86 | -0.73 | -0.046 | -9.54 | -0.62 | 0.64 | -0.36 | -0.16 |
EPS Diluted
| -1.07 | -0.71 | 0.93 | -0.48 | -0.35 | -0.57 | -0.48 | -0.023 | -1.07 | -1.86 | -0.73 | -0.046 | -9.54 | -0.62 | 0.64 | -0.36 | -0.16 |
EBITDA
| -21.565 | -6.456 | -11.213 | -27.334 | -18.785 | -21.549 | -23.007 | -23.866 | -15.347 | -14.837 | -14.532 | -7.6 | -6.651 | 1.876 | 15.03 | -1.835 | 0 |
EBITDA Ratio
| -0.434 | -0.368 | -0.317 | -1.73 | -5.406 | -11.579 | -2.108 | -13.661 | -4.997 | -5.018 | 10.41 | -2.641 | -12.717 | 0.167 | 0 | 0 | 0 |